Rising Incidence of Chronic Diseases Creates Surging Demand for Peptide Antibiotics Market || Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Peptide Antibiotics Global Market Report 2023 the increase in the prevalence of various infectious diseases is the major driver for the peptide antibiotics market's growth in the forecast period. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpins the antibacterial activity. For instance, in July 2022, according to the Australian Institute of Health and Welfare, an organization that provides data and statistics about Australia's welfare and health, the cases of notifiable infectious diseases in Australia grew from 2.89 million cases in 2020 to 7.02 million cases in 2021.

The global peptide antibiotics market size grew from $4.23 billion in 2022 to $4.58 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The peptide antibiotics market size is expected to grow to $6.22 billion in 2027 at a CAGR of 7.9%.

Download Free Sample Of Peptide Antibiotics Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Major competitors in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Theravance Biopharma, Pacgen Life Science Corporation, Kasten, Savara Pharmaceuticals, Merck KGaA.

A key trend in the peptide antibiotics market includes strategic partnership. Major companies operating in the peptide antibiotics market are entering into partnerships to expand their market and leverage each others resources. For intsance, in January 2022, Berkeley Lights, a US-based digital cell biology company, partnered with Aanika Biosciences. In this partnership, Aanika will leverage Berkeley Lights' high-throughput, functional screening service to swiftly find and refine functional antimicrobial peptides (AMPs) capable of eliminating dangerous bacteria, particularly those that cause foodborne disease outbreaks.

Read More On The Global Peptide Antibiotics Market Report Here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

The Peptide Antibiotics market is segmented -

• By Type: Ribosomal Synthesized Peptide Antibiotics, Non-rRibosomal Synthesized Peptide Antibiotics

• By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

• By Disease Outlook: Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases

• By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the peptide antibiotics market.

The Business Research Company's "Global Peptide Antibiotics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Peptide Antibiotics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

The Table Of Content For The Peptide Antibiotics Market Include:
1. Executive Summary
2. Peptide Antibiotics Market Characteristics
3. Peptide Antibiotics Market Trends And Strategies
4. Peptide Antibiotics Market - Macro Economic Scenario
5. Peptide Antibiotics Market Size And Growth
……………
27. Peptide Antibiotics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Peptide Antibiotics Market
29. Peptide Antibiotics Market Future Outlook And Potential Analysis
30. Appendix

Contact us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.